跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine
Shih Fan Jang
*
, Wei Hsiu Liu
, Wen Shin Song
, Kuan Lin Chiang
, Hsin I. Ma
,
Chung Lan Kao
, Ming Teh Chen
*
此作品的通信作者
醫學系復健醫學科
研究成果
:
Review article
›
同行評審
15
引文 斯高帕斯(Scopus)
總覽
指紋
指紋
深入研究「Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Nanomedicine
100%
Stem Cell Therapy
100%
Personalized Medicine
100%
Induced Pluripotent Stem Cells (iPSCs)
100%
Neuroprotective Strategies
100%
Nanotechnology
60%
Nanoparticles
40%
Healthcare
20%
On-state Current
20%
Stem Cells
20%
Nanosized Particles
20%
Adult Cells
20%
Reduced Toxicity
20%
Chemotherapy
20%
Patient-centered
20%
Nanoporous Silica
20%
Drug Development
20%
Biological Studies
20%
Diagnostic Tool
20%
Drug Delivery System
20%
Lipid Nanoparticles
20%
Neurodegenerative Diseases
20%
Mesoporous Silica Nanoparticles
20%
Cell Trafficking
20%
Disease Treatment
20%
Targeted Site
20%
Sparsely Populated
20%
Polymeric Nanoparticles
20%
Stem Cell Application
20%
Therapeutic Model
20%
Specific Patient
20%
Drug Bioavailability
20%
Neuroprotective
20%
Stem Cell Research
20%
Development Screening
20%
Therapeutical Applications
20%
Nanostructured Particles
20%
Transplantation Medicine
20%
Nanomedical
20%
Maladies
20%
Pharmaceutical Study
20%
Medicine and Dentistry
Personalized Medicine
100%
Nanomedicine
100%
Neuroprotective Agent
100%
Nanoparticle
100%
Induced Pluripotent Stem Cell
100%
Stem Cell
40%
Diseases
40%
Arm
20%
Medicine
20%
Diagnosis
20%
Malignant Neoplasm
20%
Embryonic Stem Cell
20%
Drug Delivery System
20%
Side Effect
20%
Cell Migration
20%
Combination Therapy
20%
Degenerative Disease
20%
Medical Device
20%
Mesoporous Silica Nanoparticle
20%
Drug Bioavailability
20%
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Nanomedicine
100%
Neuroprotective Agent
100%
Diseases
50%
Malignant Neoplasm
25%
Bioavailability
25%
Drug Delivery System
25%
Side Effect
25%
Chemotherapy
25%
Drug Development
25%
Combination Therapy
25%
Solid Lipid Nanoparticle
25%
Degenerative Disease
25%
Mesoporous Silica Nanoparticle
25%
Material Science
Stem Cell
100%
Nanoparticle
50%
Mesoporous Silica
12%
Polymer Nanoparticles
12%
Silica Nanoparticle
12%
Solid Lipid Nanoparticle
12%
Medical Device
12%
Chemical Engineering
Nanoparticle
100%
Nanomedicine
100%